Abstract
Accurate delineation of the gross tumour volume (GTV) in radiation therapy process is mandatory, especially when sophisticated techniques for radiotherapy delivery are used. Functional imaging, particularly PET and its fusion with anatomical modalities, such as PET/CT, promises to improve detection and characterization of disease. Quantitative accuracy in PET imaging is affected by several factors, which influence PET data so as to accurately delineate volume for radiotherapy planning purpose. Several strategies in using PET for target volume definition in radiotherapy treatment planning are being explored in the last years. In the present paper we give an overview of different techniques proposed to generate PET-based tumour volumes and the potential of their use in the radiation oncology process.
Keywords: PET/CT, tumour volume, radiotherapy
Current Radiopharmaceuticals
Title: Use of Positron Emission Tomography for Target Volume Definition
Volume: 2 Issue: 3
Author(s): Federica Fioroni, Elisa Grassi, Roberto Sghedoni, Marco Antonio Sarti, Annibale Versari, Salvo Diana and Gianni Borasi
Affiliation:
Keywords: PET/CT, tumour volume, radiotherapy
Abstract: Accurate delineation of the gross tumour volume (GTV) in radiation therapy process is mandatory, especially when sophisticated techniques for radiotherapy delivery are used. Functional imaging, particularly PET and its fusion with anatomical modalities, such as PET/CT, promises to improve detection and characterization of disease. Quantitative accuracy in PET imaging is affected by several factors, which influence PET data so as to accurately delineate volume for radiotherapy planning purpose. Several strategies in using PET for target volume definition in radiotherapy treatment planning are being explored in the last years. In the present paper we give an overview of different techniques proposed to generate PET-based tumour volumes and the potential of their use in the radiation oncology process.
Export Options
About this article
Cite this article as:
Fioroni Federica, Grassi Elisa, Sghedoni Roberto, Sarti Antonio Marco, Versari Annibale, Diana Salvo and Borasi Gianni, Use of Positron Emission Tomography for Target Volume Definition, Current Radiopharmaceuticals 2009; 2 (3) . https://dx.doi.org/10.2174/1874471010902030144
DOI https://dx.doi.org/10.2174/1874471010902030144 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vitamin D3 and Vitamin D3 Analogues as an Adjunct to Cancer Chemotherapy and Radiotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Therapeutic Agents Based on DNA Sequence Specific Binding
Current Topics in Medicinal Chemistry HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews In Vitro Antitumoral Activity of Palladium(II) and Platinum(II) Complexes with O,O'-Dialkyl Esters of Ethylene-bis(S)-Leucine
Letters in Drug Design & Discovery Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology
Current Drug Discovery Technologies Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery H+-myo-Inositol Transporter SLC2A13 as a Potential Marker for Cancer Stem Cells in an Oral Squamous Cell Carcinoma
Current Cancer Drug Targets Metabolism and the Paradoxical Effects of Arsenic: Carcinogenesis and Anticancer
Current Medicinal Chemistry Chylothorax
Current Respiratory Medicine Reviews Editorial [Immunogenicity of Biotherapeutics: A Need for Consensus on Flexibility of Approach (Guest Editor: Stewart Barker)]
Current Drug Safety Helical Tomotherapy versus Conventional Technique for Post Mastectomy Left Sided Breast Cancer; Dosimetric Study
Reviews on Recent Clinical Trials Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients
Current Drug Targets Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Current Medicinal Chemistry Boron Containing Macromolecules and Nanovehicles as Delivery Agents for Neutron Capture Therapy†
Anti-Cancer Agents in Medicinal Chemistry DNMT Inhibitors in Cancer, Current Treatments and Future Promising Approach: Inhibition of Specific DNMT-Including Complexes
Epigenetic Diagnosis & Therapy (Discontinued) Anti-EGFR Binding Nanobody Delivery System to Improve the Diagnosis and Treatment of Solid Tumours
Recent Patents on Anti-Cancer Drug Discovery Bcl-2 Family Proteins as Therapeutic Targets
Current Pharmaceutical Design Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid
Current Drug Targets